76 related articles for article (PubMed ID: 1807968)
1. [Implications of 5-HT2 receptors in the increase of slow wave sleep in healthy volunteers under amoxapine].
Loas G
Encephale; 1991 Dec; 17 Spec No 3():423-5. PubMed ID: 1807968
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration].
Wei HB; Niu XY
Yao Xue Xue Bao; 1990; 25(12):881-5. PubMed ID: 1966571
[TBL] [Abstract][Full Text] [Related]
3. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
van Laar M; Volkerts E; Verbaten M
Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
[TBL] [Abstract][Full Text] [Related]
4. Ritanserin-induced changes in sleep-waking phases in rats.
Kirov R; Moyanova S
Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat.
Maudhuit C; Jolas T; Lainey E; Hamon M; Adrien J
Neuropharmacology; 1994 Aug; 33(8):1017-25. PubMed ID: 7845548
[TBL] [Abstract][Full Text] [Related]
6. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
[TBL] [Abstract][Full Text] [Related]
7. [Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats].
Gozlan H; Saddiki-Traki F; Merahi N; Laguzzi R; Hamon M
Encephale; 1991 Dec; 17 Spec No 3():415-22. PubMed ID: 1666997
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT2 antagonist ritanserin decreases sleep in cats.
Sommerfelt L; Ursin R
Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
[TBL] [Abstract][Full Text] [Related]
9. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
Viola AU; Brandenberger G; Toussaint M; Bouhours P; Paul Macher J; Luthringer R
Clin Neurophysiol; 2002 Mar; 113(3):429-34. PubMed ID: 11897543
[TBL] [Abstract][Full Text] [Related]
10. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
[TBL] [Abstract][Full Text] [Related]
11. The effects of 5-HT2 antagonism on slow wave sleep in major depression: relationship with clinical aspects.
Staner L; Kempenaers C; Fransolet L; Mendlewicz J
Acta Psychiatr Belg; 1992; 92(3):182. PubMed ID: 1345435
[No Abstract] [Full Text] [Related]
12. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
[TBL] [Abstract][Full Text] [Related]
13. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat.
Dugovic C; Leysen JE; Wauquier A
Neurosci Lett; 1989 Oct; 104(3):320-5. PubMed ID: 2510097
[TBL] [Abstract][Full Text] [Related]
14. Effect of pharmacologic treatments on the sleep of depressed patients.
Sharpley AL; Cowen PJ
Biol Psychiatry; 1995 Jan; 37(2):85-98. PubMed ID: 7718684
[TBL] [Abstract][Full Text] [Related]
15. The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat.
Dugovic C; Leysen JE; Janssen PF; Wauquier A
Pharmacol Biochem Behav; 1989 Nov; 34(3):533-7. PubMed ID: 2516324
[TBL] [Abstract][Full Text] [Related]
16. Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?
Friston KJ; Sharpley AL; Solomon RA; Cowen PJ
Psychopharmacology (Berl); 1989; 98(1):139-40. PubMed ID: 2498958
[TBL] [Abstract][Full Text] [Related]
17. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power.
Brandenberger G; Luthringer R; Muller G; Gronfier C; Schaltenbrand N; Macher JP; Muzet A; Follenius M
J Endocrinol Invest; 1996 Sep; 19(8):556-62. PubMed ID: 8905480
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
19. 5-HT2 receptor antagonism and slow-wave sleep in major depression.
Staner L; Kempenaers C; Simonnet MP; Fransolet L; Mendlewicz J
Acta Psychiatr Scand; 1992 Aug; 86(2):133-7. PubMed ID: 1529736
[TBL] [Abstract][Full Text] [Related]
20. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Costall B; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
